In 2014, can we do better than CA125 in the early detection of ovarian cancer?
World Journal of Biological Chemistry · 2014 · 5 (3) · 286
DOI: 10.4331/wjbc.v5.i3.286 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift World Journal of Biological Chemistry, 2014. Verfasst von Joshua G Cohen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Joshua G Cohen, Matthew White, Ana Cruz, Robin Farias-Eisner, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University o…. Die Arbeit wurde bisher 52-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Joshua G Cohen, Matthew White, Ana Cruz, Robin Farias-Eisner, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095, Unite…
Zitieren
APA
Cohen, J. G., White, M., Cruz, A., & Farias-Eisner, R. (2014). In 2014, can we do better than CA125 in the early detection of ovarian cancer?. World Journal of Biological Chemistry, 5(3), 286. https://doi.org/10.4331/wjbc.v5.i3.286
Vancouver
Cohen JG, White M, Cruz A, Farias-Eisner R. In 2014, can we do better than CA125 in the early detection of ovarian cancer?. World Journal of Biological Chemistry. 2014;5(3):286. doi:10.4331/wjbc.v5.i3.286
BibTeX
@article{Cohen2014,
author = {Cohen, Joshua G and White, Matthew and Cruz, Ana and Farias-Eisner, Robin},
title = {In 2014, can we do better than CA125 in the early detection of ovarian cancer?},
journal = {World Journal of Biological Chemistry},
year = {2014},
volume = {5},
number = {3},
pages = {286},
doi = {10.4331/wjbc.v5.i3.286}
}
EUVIMED